EUVIMEDEUVIMED entdecken
Crossref

Formulation and evaluation of topical piroxicam microemulgel for arthritis

Mehreen Sattar, Somia Sarfraz, Uzma Liaquat, Iqra Shoukat, Bilal Ahmad, Talib Hussain

Journal of Contemporary Pharmacy · 2023

DOI: 10.56770/jcp.2023713 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Contemporary Pharmacy, 2023. Verfasst von Mehreen Sattar und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Piroxicam is an anti-inflammatory, analgesic, and antipyretic drug. Piroxicam is widely used in the management of chronic pain. The objective of this work was to develop and analyze topical Piroxicam microemulgel to improve drug solubility, enhance permeation, reduce GIT side effects reduce the frequency of the drug.

Method

The Piroxicam microemulgel was prepared by drawing the pseudo ternary phase picture and water titration procedure. Formulation was prepared by using isopropyl myristate as an oil, Tween 80 as an surfactant, n-butanol as Co-surfactant and water. It was converted to gel by using 1% Carbopol 940 and few drops of ethanolamine. The prepared formulation was characterized for thermodynamic stability, pH, droplet size, viscosity, FTIR,DSC, electrical conductivity, dye solubility drug content, and in-vitro release using a Franz diffusion cell.

Result

Microemulgel formulation was thermodynamically stable on visual inspection after being treated with a freeze-thaw cycle and centrifugation. pH of formulation was 6.5. The mean droplet size for ME gel was 100±0.472nm. The viscosity of the microemulgel was 90.4±0.01 cps which showed Newtonian flow. FTIR and DSC studies showed that microemulgel was compatible with its excipients. Electrical conductivity and dye solubility testing confirmed that the microemulgel was O/W. Piroxicam microemulsion gel showed 89.89% drug content and the release rate of piroxicam was 98±8.63% after 48h. It followed the Korsmeyer Pappas model which means it was a hydrogel-based system.

Conclusion

Microemulsion gel formulation obtained remarkably inflated skin retention for piroxicam over the piroxicam gel. It might act as a promising vehicle for the topical delivery of poor water-soluble drugs.

Zitieren

APA

Sattar, M., Sarfraz, S., Liaquat, U., Shoukat, I., Ahmad, B., & Hussain, T. (2023). Formulation and evaluation of topical piroxicam microemulgel for arthritis. Journal of Contemporary Pharmacy. https://doi.org/10.56770/jcp.2023713

Vancouver

Sattar M, Sarfraz S, Liaquat U, Shoukat I, Ahmad B, Hussain T. Formulation and evaluation of topical piroxicam microemulgel for arthritis. Journal of Contemporary Pharmacy. 2023. doi:10.56770/jcp.2023713

BibTeX
@article{Sattar2023,
  author = {Sattar, Mehreen and Sarfraz, Somia and Liaquat, Uzma and Shoukat, Iqra and Ahmad, Bilal and Hussain, Talib},
  title = {Formulation and evaluation of topical piroxicam microemulgel for arthritis},
  journal = {Journal of Contemporary Pharmacy},
  year = {2023},
  doi = {10.56770/jcp.2023713}
}
Kostenlos starten →